Sisram Medical Ltd (1696.HK)

HKD 4.53

(2.72%)

EBITDA Summary of Sisram Medical Ltd

Sisram Medical Ltd's latest annual EBITDA in 2023 was 53.42 Million USD , down -8.85% from previous year.
Sisram Medical Ltd's latest quarterly EBITDA in 2023 FY was N/A , down -8.85% from previous quarter.
Sisram Medical Ltd reported an annual EBITDA of 58.37 Million USD in 2022, up 5.67% from previous year.
Sisram Medical Ltd reported an annual EBITDA of 55.96 Million USD in 2021, up 99.18% from previous year.
Sisram Medical Ltd reported a quarterly EBITDA of 11.28 Million USD for 2023 Q4, down 0.0% from previous quarter.
Sisram Medical Ltd reported a quarterly EBITDA of 11.28 Million USD for 2023 Q3, down -9.49% from previous quarter.

Annual EBITDA Chart of Sisram Medical Ltd (2023 - 2014)

Historical Annual EBITDA of Sisram Medical Ltd (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	53.42 Million USD	-8.85%
2022	58.37 Million USD	5.67%
2021	55.96 Million USD	99.18%
2020	28.18 Million USD	-19.81%
2019	35.29 Million USD	18.57%
2018	29.54 Million USD	9.27%
2017	27.01 Million USD	11.36%
2016	24.43 Million USD	2.21%
2015	23.76 Million USD	6.67%
2014	22.07 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2023 FY	- USD	-8.85%
2023 Q4	11.28 Million USD	0.0%
2023 Q3	11.28 Million USD	-9.49%
2023 Q2	12.46 Million USD	0.0%
2023 Q1	12.46 Million USD	-4.51%
2022 Q4	13.05 Million USD	0.0%
2022 FY	- USD	5.67%
2022 Q3	13.05 Million USD	-6.37%
2022 Q2	13.94 Million USD	0.0%
2022 Q1	13.94 Million USD	8.68%
2021 Q1	12.96 Million USD	79.92%
2021 Q4	12.82 Million USD	0.0%
2021 FY	- USD	99.18%
2021 Q2	12.96 Million USD	0.0%
2021 Q3	12.82 Million USD	-1.04%
2020 Q1	4.69 Million USD	-23.6%
2020 Q2	4.69 Million USD	0.0%
2020 Q3	7.2 Million USD	53.48%
2020 FY	- USD	-19.81%
2020 Q4	7.2 Million USD	0.0%
2019 Q4	6.14 Million USD	0.0%
2019 FY	- USD	18.57%
2019 Q3	6.14 Million USD	-32.03%
2019 Q1	9.04 Million USD	18.92%
2019 Q2	9.04 Million USD	0.0%
2018 Q3	7.6 Million USD	-6.29%
2018 FY	- USD	9.27%
2018 Q1	8.11 Million USD	23.56%
2018 Q4	7.6 Million USD	0.0%
2018 Q2	8.11 Million USD	0.0%
2017 Q1	8.67 Million USD	33.78%
2017 FY	- USD	11.36%
2017 Q3	6.56 Million USD	3.24%
2017 Q2	6.36 Million USD	-26.69%
2017 Q4	6.56 Million USD	0.0%
2016 FY	- USD	2.21%
2016 Q2	6.98 Million USD	13.48%
2016 Q4	6.48 Million USD	0.0%
2016 Q1	6.15 Million USD	0.0%
2016 Q3	6.48 Million USD	-7.22%
2015 FY	- USD	6.67%
2014 FY	- USD	0.0%

Peer EBITDA Comparison of Sisram Medical Ltd

Name	EBITDA	EBITDA Difference
Vincent Medical Holdings Limited	104.43 Million HKD	48.838%